Lindbrook Capital, LLC Aclaris Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$0.64 - $6.49 $63 - $642	99 Added 34.86%	383 $0
Q3 2023 Oct 25, 2023	BUY	$6.56 - $10.95 $1,640 - $2,737	250 Added 735.29%	284 $1,000
Q2 2023 Jul 28, 2023	BUY	$7.89 - $10.64 $268 - $361	34 New	34 $0
Q4 2022 Jan 24, 2023	SELL	$14.33 - $18.37 $444 - $569	-31 Reduced 12.97%	208 $0
Q3 2022 Nov 10, 2022	BUY	$13.07 - $18.22 $405 - $564	31 Added 14.9%	239 $4,000
Q1 2022 Apr 21, 2022	BUY	$9.74 - $17.92 $2,025 - $3,727	208 New	208 $4,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.